Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline parvovirus and feline herpes virus

Details for Australian Patent Application No. 2006273753 (hide)

Owner Pfizer Products Inc.

Inventors Rong, Sing; Guimond, Paul Mark; Tucker, Cassius McAllister; Newbuy, Thomas Jack; Clare, Paula Munns; Lowery, David Earl

Agent Spruson & Ferguson

Pub. Number AU-B-2006273753

PCT Pub. Number WO2007/012944

Priority 60/703,109 28.07.05 US

Filing date 17 July 2006

Wipo publication date 1 February 2007

Acceptance publication date 24 June 2010

International Classifications

C07K 14/08 (2006.01) Peptides having more than 20 amino acids

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/40 (2006.01) Mutation or genetic engineering - Proteins from RNA viruses, e.g. flaviviruses

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2007/012944 Priority application(s): WO2007/012944

3 April 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 03 Mar 2008 2006275442 3M Innovative Properties Company The nature of the amendment is as shown in the statement(s) filed 06 Mar 2008

15 May 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline parvovirus and feline herpes virus

26 June 2008 Section 223 Application Received

  Pfizer Products Inc. An application to extend the time from 31 Jan 2007 to 31 Mar 2008 in which to comply with section 6(c) has been filed . Address for service in Australia - Spruson & Ferguson St Martins Tower Level 35 31 Market Street Sydney NSW 2000

14 August 2008 Section 223 Application Allowed

  Pfizer Products Inc. The time in which to comply with section 6(c) has been extended to 31 Mar 2008. Address for service in Australia - Spruson & Ferguson St Martins Tower Level 35 31 Market Street Sydney NSW 2000

24 June 2010 Application Accepted

  Published as AU-B-2006273753

21 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006273756-Method of treating ischemia-reperfusion injury

2006273747-Heat engine